Dr D'Alessio is Professor of Medicine at the University of Cincinnati School of Medicine and Director of the Division of Endocrinology at the University of Cincinnati . He is a staff physician at the Cincinnati VA Medical Center, attending physician at the University of Cincinnati Hospital, and Chief of the Endocrinology and Diabetes Clinic at the Cincinnati VA Medical Center.
Dr D'Alessio received his medical degree from the University of Wisconsin in Madison , Wisconsin . His primary research interests are in the regulation of glucose tolerance and abnormalities that lead to glucose tolerance in type 2 diabetes. Work in his lab focuses on the interplay between circulating glucose, GI hormones, and neural signals to control insulin secretion. Dr D'Alessio is actively involved in research examining the regulation of glucose tolerance by GLP-1 in nondiabetic and diabetic persons; the ability of GI hormones to mediate food intake and energy balance in response to diets of differing macronutrient content; and the mechanisms by which GLP-1 suppresses food intake.
Throughout his career, Dr D'Alessio has been the recipient of many honors, including the Howard Hughes Medical Institute Research Resources Program Award, the American Diabetes Association Clinical Research Award, and the Paul Beeson Award for Clinical Teaching. Additionally, he has authored over 60 peer-reviewed scientific publications and serves as a scientific reviewer for numerous journals in the areas of endocrinology, gastroenterology, and pediatrics.
Henry N Ginsberg, MD
Henry N. Ginsberg, MD, is the Irving Professor of Medicine at the Columbia University College of Physicians and Surgeons and Director of the Irving Institute for Clinical and Translational Research, Columbia University Medical Center, New York, New York. He earned his medical degree from the SUNY Downstate Medical Center College of Medicine, Brooklyn , New York , and completed training in internal medicine at the Boston University Service of the Boston City Hospital in Massachusetts . Dr Ginsberg trained in endocrinology and metabolism at Stanford University School of Medicine in California .
Dr Ginsberg is principal investigator on two R01 research grants from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute. He is also the principal investigator of an NIH Training Grant in Arteriosclerosis. Dr Ginsberg is principal investigator on the new NIH-funded Clinical Translational Science Award, (CTSA), at Columbia . The Irving Institute is the home for the CTSA.
Dr Ginsberg's research interests have focused on the regulation of plasma cholesterol and triglyceride blood levels, particularly the metabolism of apolipoprotein B–containing lipoproteins in humans, mice, and cultured liver cells. Much of his present work focuses on the interaction between insulin resistance and increased secretion of very low density lipoproteins by the liver.
Dr Ginsberg is on the editorial boards of Journal of Clinical Investigation, Journal of Lipid Research, and Journal of Metabolism . He has authored or coauthored more than 200 articles, reviews, and chapters related to lipids, diabetes, and heart disease. Dr Ginsberg actively participates in such national organizations as the American Heart Association (AHA) and the American Diabetes Association. He is a Fellow of the AHA Council on Arteriosclerosis, Thrombosis and Vascular Biology, and past-Chair of its Leadership Committee. He is also a Fellow of the AHA Council on Nutrition, Physical Activity and Metabolism and the American Association for the Advancement of Science. Dr Ginsberg is a member of the American Society for Clinical Investigation and the Association of American Physicians. He was recently named as an honorary member of the American Dietetic Association.
Robert R Henry, MD
Robert R Henry, MD, is Professor of Medicine in the Division of Endocrinology and Metabolism at the University of California, San Diego. Dr Henry received his medical degree from the University of Manitoba Medical School, Manitoba, Canada, where he also completed his residency in internal medicine and fellowship in endocrinology. He has been Visiting Assistant Professor of Medicine, Diabetic Research Unit, at the University of Colorado Health Sciences Center; Visiting Assistant Research Endocrinologist at the University of California, San Diego; and Visiting Professor of Medicine at the University of Edinburgh, Royal Infirmary.
He is a member of several professional societies including the American Diabetes Association, the American Heart Association, the Endocrine Society, the Royal College of Physicians and Surgeons of Canada, and the American Federation for Clinical Research. Dr Henry’s honors include awards from the American Board of Internal Medicine and the American Board of Endocrinology and Metabolism. He is also a Fellow of the Royal College of Physicians and Surgeons of Canada.
Dr Henry's primary research interests involve studies in the etiology, treatment, and prevention of obesity and type 2 diabetes. He has authored more than 200 scientific journal articles and book chapters, the most recent publications describing the metabolic and cardiovascular effects of novel therapies for insulin resistance and diabetes, as well as defects of insulin signal transduction in skeletal muscle and adipose tissue of type 2 diabetic subjects.
Willa A Hsueh, MD
Willa A. Hsueh, MD, is Professor of Medicine and Director, Diabetes Research Center , The Methodist Hospital Research Institute and Chief, Division of Diabetes, Obesity and Lipids, Department of Medicine, The Methodist Hospital in Houston , TX . Dr Hsueh received her MD cum laude from Ohio State University and performed postgraduate training in Internal Medicine at Johns Hopkins Hospital . She was a clinical fellow in endocrinology at Johns Hopkins Hospital and a research fellow at Stanford University School of Medici ne.
Her current research interests focus on insulin resistance and mechanisms of cardiovascular disease, nuclear receptors, the renin-angiotensin system, and cardiovascular and renal complications of diabetes mellitus, with the goal of translating observations at the bench to human pathophysiology and prevention of disease. Her group was the first to identify a potentially protective role for ligands to the nuclear receptor, peroxisome proliferator activated receptor γ (PPARγ) in vascular injury and more recently, in diabetes complications, particularly in regulation of genes that may mediate complications. The PPAR class of therapeutics are emerging as an important strategy in the war against the metabolic syndrome and diabetes.
Dr Hsueh and her colleagues also demonstrated that coronary vascular damage occurs in insulin resistance in the absence of traditional cardiovascular disease risk and may be related to adipokine production by fat cells and inflammatory changes, all of which are improved by PPAR ligands. Evidence from her laboratory team suggests these agents may also be useful in models of type 1 and type 2 diabetes to prevent renal damage. Her group has also identified mechanisms of angiotensin II tissue damage in diabetes and recently reported a novel effect to inhibit reverse cholesterol transport. Dr Hsueh is a fellow of the Council for High Blood Pressure Research of the American Heart Association and presented their Arthur Corcoran Memorial
Lectureship in 2004. She is a member of numerous other professional societies, including the American Society for Clinical Investigation and the American Association of Physicians. She served on the American Board of Internal Medicine, Endocrinology, Metabolism and Diabetes Committee and on the Advisory Committee for The National Heart, Lung and Blood Institute. Dr Hsueh was listed among The Best Doctors in America in Endocrinology from 1998 through 2008, and has received many awards, including a MERIT Award of the National Institute of Arthritis, Metabolism, and Digestive Diseases, the Harry Goldblatt Award for Cardiovascular Research of the American Heart Association, and the Edwin B. Astwood Award for Outstanding
Research from the Endocrine Society. She was also Principal Investigator on the NIH funded UCLA-UCSD Diabetes Endocrinology Research Center .
Scott V Joy, MD, CDE, FACP
Scott V Joy, MD, CDE, FACP is an Associate Clinical Professor of Medicine in the Department of Medicine, and the Clinical Chief of the Division of General Internal Medicine at Duke University Medical Center in Durham, North Carolina. Dr Joy received his medical degree from University of Pittsburgh School of Medicine in Pittsburgh, Pennsylvania. His postgraduate education included a residency in internal medicine at Allegheny General Hospital in Pittsburgh. He is board certified in internal medicine, is a certified diabetes educator and a fellow of the American College of Physicians.
Dr. Joy’s research interests include process improvement in diabetes management and education, evaluation of new drug therapies for diabetes, clinical evaluation of postprandial hyperglycemia and applications of technology into clinical practice. He has published articles and abstracts in such publications as Diabetes, Journal of Clinical Outcomes Management, The Annals of Pharmacotherapy, Pediatric Hematology and Oncology, Journal of General Internal Medicine, and MD News. He is a member of the Eastern North Carolina American Diabetes Association Leadership Council and is a current member of the state of North Carolina Diabetes Advisory Council.
Davida Kruger, MSN, APRN-BC , BC -ADM
Davida Kruger, MSN, APRN-BC , BC -ADM, is a Certified Nurse Practitioner specializing in diabetes at the Henry Ford Health System in Detroit , Michigan . She received her Master of Science in Nursing from Wayne State University in 1982. She is a Board Certified Nurse Practitioner in Advanced Diabetes Management, as well as a Certified Adult Nurse Practitioner. Her current position combines both clinical practice and research, and she has served as a trial coordinator/coinvestigator for both the Diabetes Control and Complications Trial (DCCT) and the Epidemiology of Diabetes Intervention and Complications (EDIC).
Additionally, she has been actively involved in the American Diabetes Association, serving on the national, regional, and local levels. She has also published extensively in endocrinology and nursing journals on a number of topics, including insulin self-administration, blood glucose self-monitoring, and the role of hormonal interplay in glucose regulation.
F. Xavier Pi Sunyer, MD, MPH
F. Xavier Pi Sunyer, MD, MPH, is Professor of Medicine at the Columbia University College of Physicians and Surgeons and Professor of Applied Physiology at the Columbia Teachers College , Columbia University , both in New York City . At St. Luke's-Roosevelt Hospital Center in New York, he serves as Senior Attending Physician; Chief of the Division of Endocrinology, Diabetes, and Nutrition; and Director of the Obesity Research Center. Dr Pi-Sunyer is also Senior Attending Physician at New York-Presbyterian Hospital.
After receiving his BA in 1955 from Oberlin College in Ohio , Dr Pi-Sunyer went on to complete his MD from the College of Physicians and Surgeons at Columbia University in New York . In 1963, he was granted his MPH from Harvard University School of Public Health in Cambridge , Massachusetts .
A native of Barcelona , Spain , Dr Pi-Sunyer's distinguished career has expanded well past the borders of the US , beginning with his postdoctoral training, which took him to England and Nigeria with fellowships in the areas of research, medicine, and clinical nutrition. As a Fellow, invited speaker, Visiting Professor, and participant on numerous boards and task forces, he has worked in the Far East, Europe, Africa, and Latin America.
Dr Pi-Sunyer is a distinguished member of many national medical and scholastic societies. He has dedicated over 25 years of service to the American Diabetes Association, serving as President (1992-1993) and chairing numerous committees at the national, state, and local levels. In 1993, he was awarded the Banting Medal for Service from the American Diabetes Association.
Having contributed chapters to over 100 medical texts, Dr Pi-Sunyer is a prolific writer of articles for international peer-reviewed journals and the lay press. Since 1994, he has been the Associate Editor for the International Journal of Obesity and serves as a Journal Referee for over 20 professional journals.
Arturo Rolla, MD
Dr Rolla earned his medical degree from the Catholic University of Cordoba Medical School in Argentina . He completed his residency in internal medicine at the New England Deaconess Hospital in Boston , where he was Chief Resident, and a fellowship in endocrinology and metabolism at the Joslin Clinic, where he was Chief Fellow.
Dr Rolla is presently a consulting endocrinologist at the Beth Israel Deaconess Medical Center in Boston , and an Assistant Clinical Professor of Medicine at both Harvard Medical School and Tufts University School of Medicine in Boston . He is a member of the American Diabetes Association, the International Diabetes Federation, the American Association of Clinical Endocrinologists, and the Massachusetts Medical Society.
Dr Rolla has published numerous articles and book chapters in the field of endocrinology and diabetes. Additionally, he serves as a manuscript reviewer for numerous scientific publications, including the Journal of Clinical Endocrinology and Metabolism, Endocrine Practice, Archives of Internal Medicine, Diabetes Care, New England Journal of Medicine, Latin American Diabetes Association Bulletin, Archives of Internal Medicine, Diabetes Care, the Journal of the American Association of Gynecologic Laparoscopists, and Evidence-Based Medicine. Dr Rolla also is a book reviewer for the New England Journal of Medicine, an article reviewer for the American College of Physicians Journal Club, and an invited editor of the Diabetes Newsletter. His professional interests include diabetes, thyroid cancer, Klinefelter's syndrome, and hemochromatosis. Dr Rolla has received awards for Best Clinical Teacher and is an Honorary Professor of several medical schools around the world.